Back

Testosterone loss as essential parameter of silent target organ damage in primary hypertension

29 August 2016 (16:03 - 16:10)
Organised by:
Congress Presentation Part of: Complications of hypertension Hypertension, other ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Athanasios Angelis

Ippokrateio General Hospital of Athens, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Low testosterone and high C-reactive protein are complementary determinants of global arterial function and early structural changes in men with arterial hypertension
Doctor N. Ioakeimidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Longitudinal changes of the serum calcium levels and accelerated progression of arterial stiffness with age.
Doctor K. Kimura (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Angiotensin receptor-1 antagonists improve endothelial glycocalyx and aortic stiffness after 2 years successful treatment in untreated patients with essential hypertension
Doctor H. Triantafyllidi (Athens, GR)
Abstract Slides
Presentation thumbnail
Evaluation of coronary flow velocity by Doppler echocardiography in the treatment of hypertension with the ACEi/ARB: correlation to the histological cardiac fibrosis
Doctor C. Wei-Ting (Tainan, TW)
Abstract Slides
Presentation thumbnail
Correlation between cognitive decline and blood pressure in elderly patients with controlled hypertension
Mr A. Noriega de la Colina (Montreal, CA)
Abstract Slides

Access the full session

Session thumbnail
Complications of hypertension

The Event

Event poster

ESC Congress 2016

29 August 2016 16:03 CET
You may be interested in
thumbnail
Congress Presentation
Relationship of myocardial fibrosis markers with glomerular filtration rate in patients with arterial hypertension.
29 June 2021
thumbnail
Webinar
Sex and gender in hypertension
9 March 2022
thumbnail
Congress Presentation
Testosterone promote myocardial hypertrophy in postmenopausal hypertensive women by regulating the plasma membrane transition of the cardiomyocytes.
1 September 2025
thumbnail
Congress Presentation
Primary hyperaldosteronism and phaeochromocytoma
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources